Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World

References

• Meetoo D, Wong L, Fatani T. “Knowing where I am”: self-monitoring of blood glucose in diabetes. Br J Nurs. 2018;27:537–541. doi:10.12968/bjon.2018.27.10.537
   PubMedGoogle Scholar
• Boutati EI, Raptis SA. Self-monitoring of blood glucose as part of the integral care of type 2 diabetes. Diabetes Care. 2009;32:S205–10. doi:10.2337/dc09-S312
   PubMed Web of Science ®Google Scholar
• National institute for Health and Care Excellence (NICE). Type 1 diabetes in adults: diagnosis and management: NG17 [Internet]; 2026. Available from: www.nice.org.uk/guidance/ng17. Accessed January 19, 2022.
   Google Scholar
• Olansky L, Kennedy L. Finger-stick glucose monitoring. Diabetes Care. 2010;33:948–949. doi:10.2337/dc10-0077
   PubMed Web of Science ®Google Scholar
• Hortensius J, Kleefstra N, Landman GWD, et al. Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial. BMC Res Notes. 2018;11:26. doi:10.1186/s13104-018-3138-7
   PubMedGoogle Scholar
• Polonsky WH, Fisher L, Schikman CH, et al. A structured self-monitoring of blood glucose approach in Type 2 diabetes encourages more frequent, intensive, and effective physician interventions: Results from the STeP Study. Diabetes Technol Ther. 2011;13:797–802. doi:10.1089/dia.2011.0073
   PubMed Web of Science ®Google Scholar
• Association AD. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41:917–928. doi:10.2337/dci18-0007
   PubMed Web of Science ®Google Scholar
• Coons MJ, Greiver M, Aliarzadeh B, et al. Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study. BMJ Open Diabetes Res Care. 2017;5:e000316. doi:10.1136/bmjdrc-2016-000316
   PubMed Web of Science ®Google Scholar
• Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254–2263. doi:10.1016/S0140-6736(16)31535-5
   PubMed Web of Science ®Google Scholar
• Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55–73. doi:10.1007/s13300-016-0223-6
   PubMed Web of Science ®Google Scholar
• Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19:1294–1301. doi:10.1111/pedi.12735
   PubMed Web of Science ®Google Scholar
• Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with Type 2 diabetes. Diabetes Care. 2019;42:1178–1184. doi:10.2337/dc18-0166
   PubMed Web of Science ®Google Scholar
• Evans M, Welsh Z, Ells S, Seibold A. The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2019;11:83–95.
   Google Scholar
• Deshmukh H, Wilmot EG, Gregory R, et al. Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) nationwide audit. Diabetes Care. 2020;43:2153–2160. doi:10.2337/dc20-0738
   PubMed Web of Science ®Google Scholar
• Kröger J, Fasching P, Hanaire H. Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with Type 2 diabetes. Diabetes Ther. 2020;11:279–291. doi:10.1007/s13300-019-00741-9
   PubMed Web of Science ®Google Scholar
• Elliott T, Beca S, Beharry R, Tsoukas MA, Zarruk A, Abitbol A. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: a retrospective real-world chart review study. Diabetes Vasc Dis Res. 2021;18:147916412110213. doi:10.1177/14791641211021374
   Web of Science ®Google Scholar
• Wada E, Onoue T, Kobayashi T, et al. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2020;8:e001115. doi:10.1136/bmjdrc-2019-001115
   PubMed Web of Science ®Google Scholar
• Wright EE, Kerr MSD, Reyes IJ, Nabutovsky Y, Miller E. Use of flash continuous glucose monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy. Diabetes Spectr. 2021;34:184–189. doi:10.2337/ds20-0069
   PubMedGoogle Scholar
• International Hypoglycemia Study Group. Minimizing Hypoglycemia in Diabetes. Diabetes Care. 2015;38:1583–1591. doi:10.2337/dc15-0279
   PubMed Web of Science ®Google Scholar
• Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017; 40:1622-1630.
   Google Scholar
• Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–1603. doi:10.2337/dci19-0028
   PubMed Web of Science ®Google Scholar
• Beck RW, Bergenstal RM, Cheng P, et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol. 2019;13:614–626. doi:10.1177/1932296818822496
   PubMedGoogle Scholar
• Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol The. 2018;21:81–85. doi:10.1089/dia.2018.0310
   PubMed Web of Science ®Google Scholar
• Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2018;42:400–405. doi:10.2337/dc18-1444
   PubMed Web of Science ®Google Scholar
• Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370–2376. doi:10.2337/dc18-1131
   PubMed Web of Science ®Google Scholar
• Li F, Zhang Y, Li H, et al. TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes. Diabetes Res Clin Pr. 2020;166:108289. doi:10.1016/j.diabres.2020.108289
   PubMed Web of Science ®Google Scholar
• Lu J, Ma X, Shen Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes. Diabetes Technol The. 2020;22:72–78. doi:10.1089/dia.2019.0251
   PubMed Web of Science ®Google Scholar
• Lu J, Wang C, Shen Y, et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care. 2021;44:549–555. doi:10.2337/dc20-1862
   PubMed Web of Science ®Google Scholar
• Monnier L, Colette C, Wojtusciszyn A, et al. Toward defining the threshold between low and high glucose variability in diabetes. Diabetes Care. 2017;40(7):832–838. doi:10.2337/dc16-1769
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): a new term for estimating a1c from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275–2280. doi:10.2337/dc18-1581
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013;7(2):562–578. doi:10.1177/193229681300700234
   PubMedGoogle Scholar
• Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2018;7(3):221–230. doi:10.1016/S2213-8587(18)30136-0
   PubMed Web of Science ®Google Scholar
• Palylyk-Colwell E, Ford C. Flash glucose monitoring for diabetes. Can Agency Drugs Technol Health. 2016;158:1–13.
   Google Scholar
• Boucher MC. Flash glucose monitoring system - FreeStyle Libre to monitor glycemia in patients with diabetes. Report No: 2369-7385; 2020.
   Google Scholar
• CADTH. Implementation advice: freeStyle Libre flash glucose monitoring system. Report; 2020.
   Google Scholar
• Young C, Grobelna A. Flash glucose monitoring systems in pediatric populations with diabetes. Can J Health Technol. 2021;1:1–67. doi:10.51731/cjht.2021.60
   Google Scholar
• OntarioHealth:quality. Ontario health technology advisory committee [Internet]. Available from: https://hqontario.ca/Evidence-to-Improve-Care/Health-Technology-Assessment/Ontario-Health-Technology-Advisory-Committee. Accessed January 19, 2022.
   Google Scholar
• OntarioHealth:Quality. Ontario health technology advisory committee terms of reference [Internet]. Available from: https://hqontario.ca/portals/0/documents/evidence/reports/ohtac-terms-of-reference-en.pdf. Accessed January 19, 2022.
   Google Scholar
• OntarioHealth:Quality. Flash glucose monitoring system for people with type 1 or type 2 diabetes: a health technology assessment; 2019.
   Google Scholar
• INESSS. Evaluation process and criteria [Internet]. Available from: https://www.inesss.qc.ca/en/themes/medicaments/evaluation-process-and-criteria.html. Accessed January 19, 2022.
   Google Scholar
• INESSS. Avis - Système flashed surveillance du glucose. [Guide - Flash Glucose Monitoring System]. (FreeStyle Libre, Abbott); 2018.
   Google Scholar
• FreeStyle Libre - Diabète. Avis transmis à la ministre en Mars; [FreeStyle Libre - Diabetes. Advice from the Minister]; 2020. [Press release].
   Google Scholar
• Cheng AYY, Feig DS, Ho J, et al.; Diabetes Canada Clinical Practice Guidelines Expert Working Group. Blood glucose monitoring in adults and children with diabetes: update 2021. Can J Diabetes. 45;2021:580–587. doi:10.1016/j.jcjd.2021.07.003
   PubMed Web of Science ®Google Scholar
• Diabetes Canada. Results of patient & caregiver survey; 2021. Available from: https://www.diabetes.ca/DiabetesCanadaWebsite/media/Campaigns/COVID-19%20and%20Diabetes/2021-Patient-Caregiver-Survey-Results.pdf. Accessed January 19, 2022.
   Google Scholar
• Wherrett DK, Ho J, Huot C, et al.; Diabetes Canada Clinical Practice Guidelines Expert Working Group. Type 1 diabetes in children and adolescents. Can J Diabetes. 42;2018:S234–46. doi:10.1016/j.jcjd.2017.10.036
   PubMed Web of Science ®Google Scholar
• Massa GG, Gys I, Eyndt AO, et al. Evaluation of the FreeStyle® Libre flash glucose monitoring system in children and adolescents with type 1 diabetes. Horm Res Paediat. 2018;89:189–199. doi:10.1159/000487361
   PubMed Web of Science ®Google Scholar
• Deeb A, Yousef H, Qahtani NA, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metabolic Disord. 2019;18:1–6. doi:10.1007/s40200-018-0351-9
   PubMed Web of Science ®Google Scholar
• Piona C, Dovc K, Mutlu GY, et al. Non‐adjunctive flash glucose monitoring system use during summer‐camp in children with type 1 diabetes: the free‐summer study. Pediatr Diabetes. 2018;19:1285–1293. doi:10.1111/pedi.12729
   PubMed Web of Science ®Google Scholar
• Deja G, Kłeczek M, Chumięcki M, et al. The usefulness of the FlashStyle Libre system in glycemic control in children with type 1 diabetes during summer camp. Pediatric Endocrinol Diabetes Metabolism. 2018;24:11–19. doi:10.18544/PEDM-24.01.0098
   PubMedGoogle Scholar
• Messaaoui A, Tenoutasse S, Crenier L. Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use. Diabetes Technol Ther. 2019;21:329–335. doi:10.1089/dia.2018.0339
   PubMed Web of Science ®Google Scholar
• Landau Z, Abiri S, Gruber N, et al. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: aWeSoMe study group real-life observational experience. Acta Diabetol. 2018;55:1303–1310. doi:10.1007/s00592-018-1218-8
   PubMed Web of Science ®Google Scholar
• Vergier J, Samper M, Dalla-Vale F, et al. Evaluation of flash glucose monitoring after long-term use: a pediatric survey. Prim Care Diabetes. 2019;13:63–70. doi:10.1016/j.pcd.2018.08.004
   PubMed Web of Science ®Google Scholar
• Pintus D, Ng SM. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metabolic Syndrome Clin Res Rev. 2019;13:2923–2926. doi:10.1016/j.dsx.2019.07.054
   PubMed Web of Science ®Google Scholar
• Fokkert MJ, Damman A, Dijk PR, et al. Use of freestyle libre flash monitor register in the Netherlands (FLARE-NL1): Patient experiences, satisfaction, and cost analysis. Int J Endocrinol. 2019;2019:1–6. doi:10.1155/2019/4649303
   Web of Science ®Google Scholar
• Fokkert M, Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care. 2019;7:e000809. doi:10.1136/bmjdrc-2019-00080
   PubMed Web of Science ®Google Scholar
• Birtwhistle R, Green ME, Frymire E, et al. Hospital admission rates and emergency department use in relation to glycated hemoglobin in people with diabetes mellitus: a linkage study using electronic medical record and administrative data in Ontario. CMAJ Open. 2017;5:E557–64. doi:10.9778/cmajo.20170017
   PubMedGoogle Scholar
• Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018;41:1631–1638. doi:10.2337/dc17-1379
   PubMed Web of Science ®Google Scholar
• Dhatariya KK, Skedgel C, Fordham R. The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabetic Med. 2017;34:1361–1366. doi:10.1111/dme.13427
   PubMed Web of Science ®Google Scholar
• Parekh WA, Ashley D, Chubb B, Gillies H, Evans M. Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabetic Med. 2015;32:1156–1166. doi:10.1111/dme.12771
   PubMed Web of Science ®Google Scholar
• Charleer S, Block CD, Huffel LV, et al. Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a Prospective Observational Real-World Cohort Study. Diabetes Care. 2020;43:389–397. doi:10.2337/dc19-1610
   PubMed Web of Science ®Google Scholar
• Tsur A, Cahn A, Israel M, Feldhamer I, Hammerman A, Pollack R. Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: a nationwide cohort study. Diabetes Metabolism Res Rev. 2020;e3355. doi:10.1002/dmrr.3355
   PubMed Web of Science ®Google Scholar
• Roussel R, Riveline J-P, Vicaut E, et al. Important drop rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF Study. Diabetes Care. 2021;44(6):1368–1376. doi:10.2337/dc20-1690
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Kerr MSD, Roberts GJ, Souto D, Nabutovsky Y, Hirsch IB. Flash CGM is associated with reduced diabetes events and hospitalizations in insulin-treated type 2 diabetes. J Endocr Soc. 2021;5:bvab013. doi:10.1210/jendso/bvab013
   PubMed Web of Science ®Google Scholar
• Wood CL, Clements SA, McFann K, Slover R, Thomas JF, Wadwa RP. Use of telemedicine to improve adherence to American Diabetes Association standards in pediatric type 1 diabetes. Diabetes Technol The. 2016;18:7–14. doi:10.1089/dia.2015.0123
   PubMed Web of Science ®Google Scholar
• Tonyushkina KN, Cobb V, Moskovitz A, Allen HF. Televisits to partially substitute for clinic visits are feasible and well accepted by tech-savvy patients with T1DM and their families: a Prospective Pilot Study. J Diabetes Sci Technol. 2018;12:1084–1085. doi:10.1177/1932296818775438
   PubMedGoogle Scholar
• McGloin H, O’Connell D, Glacken M, et al. Patient empowerment using electronic telemonitoring with telephone support in the transition to insulin therapy in adults with type 2 diabetes: observational, pre-post, mixed methods study. J Med Internet Res. 2020;22(5):e16161. doi:10.2196/16161
   PubMed Web of Science ®Google Scholar
• Glazier RH, Green ME, Wu FC, Frymire E, Kopp A, Kiran T. Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada. CMAJ. 2021;193:E200–10. doi:10.1503/cmaj.202303
   PubMed Web of Science ®Google Scholar
• Danne T, Limbert C, Domingo MP, et al. Telemonitoring, telemedicine and time in range during the pandemic: paradigm change for diabetes risk management in the post-COVID future. Diabetes Ther. 2021;12:2289–2310. doi:10.1007/s13300-021-01114-x
   PubMed Web of Science ®Google Scholar
• Dover AR, Ritchie SA, McKnight JA, et al. Assessment of the effect of the COVID‐19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabetic Med. 2020;38(1):e14374. doi:10.1111/dme.14374
   PubMed Web of Science ®Google Scholar
• Fernández E, Cortazar A, Bellido V. Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pr. 2020;166:108348. doi:10.1016/j.diabres.2020.108348
   PubMed Web of Science ®Google Scholar
• Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. Diabetes Ther. 2020;11:1369–1379. doi:10.1007/s13300-020-00829-7
   PubMed Web of Science ®Google Scholar
• Aragona M, Rodia C, Bertolotto A, et al. Type 1 diabetes and COVID-19: the “Lockdown effect.”. Diabetes Res Clin Pr. 2020;170:108468. doi:10.1016/j.diabres.2020.108468
   PubMed Web of Science ®Google Scholar
• Capaldo B, Annuzzi G, Creanza A, et al. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care. 2020;2:dc201127.
   Google Scholar
• Marigliano M, Maffeis C. Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy. Acta Diabetol. 2021;43:1–4.
   Google Scholar
• Schiaffini R, Barbetti F, Rapini N, et al. School and pre-school children with type 1 diabetes during Covid-19 quarantine: the synergic effect of parental care and technology. Diabetes Res Clin Pr. 2020;166:108302. doi:10.1016/j.diabres.2020.108302
   PubMed Web of Science ®Google Scholar
• Mesa A, Viñals C, Pueyo I, et al. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pr. 2020;167:108354. doi:10.1016/j.diabres.2020.108354
   PubMed Web of Science ®Google Scholar
• Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R. Effects of COVID-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy. Diabetes Care. 2020;56:dc200954.
   Google Scholar
• Murphy H. Managing diabetes in pregnancy before, during and after COVID-19. Diabetes Technol The. 2020;22:454–461. doi:10.1089/dia.2020.0223
   PubMed Web of Science ®Google Scholar
• Alcántara-Aragón V. Improving patient self-care using diabetes technologies. Ther Adv Endocrinol Metabolism. 2019;10:2042018818824215. doi:10.1177/2042018818824215
   Web of Science ®Google Scholar
• Hayek AAA, Robert AA, Dawish MAA. Differences of freestyle libre flash glucose monitoring system and finger pricks on clinical characteristics and glucose monitoring satisfactions in type 1 diabetes using insulin pump. Clin Medicine Insights Endocrinol Diabetes. 2019;12:1179551419861102. doi:10.1177/1179551419861102
   Web of Science ®Google Scholar
• Hayek AAA, Dawish MAA. The potential impact of the freestyle libre flash glucose monitoring system on mental well-being and treatment satisfaction in patients with type 1 diabetes: a prospective study. Diabetes Ther. 2019;10:1239–1248. doi:10.1007/s13300-019-0616-4
   PubMed Web of Science ®Google Scholar
• Mitsuishi S, Nishimura R, Harashima S, et al. The effect of novel glucose monitoring system (flash glucose monitoring) on mental well-being and treatment satisfaction in Japanese people with diabetes. Adv Ther. 2018;35:72–80. doi:10.1007/s12325-017-0649-x
   PubMed Web of Science ®Google Scholar
• Hayek AAA, Dawish MAA. Assessing diabetes distress and sleep quality in young adults with type 1 diabetes using freestyle libre: a prospective cohort study. Diabetes Ther. 2020;11:1551–1562. doi:10.1007/s13300-020-00849-3
   PubMed Web of Science ®Google Scholar
• Nana M, Moore SL, Ang E, Lee ZX, Bondugulapati LNR. Flash glucose monitoring: impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting. Diabetes Res Clin Pr. 2019;157:107893. doi:10.1016/j.diabres.2019.107893
   PubMed Web of Science ®Google Scholar
• Hayek AAA, Robert AA, Dawish MAA. Evaluation of freestyle libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Medicine Insights Endocrinol Diabetes. 2017;10:1179551417746957. doi:10.1177/1179551417746957
   Web of Science ®Google Scholar
• Ontario Ministry of Health, Drugs and Devices Division. Notice from the executive officer: funding flash glucose monitoring system through the Ontario drug benefit program; 2019.
   Google Scholar
• The flash glucose monitoring system is now covered [press release]. Diabetes Quebec; 2019.
   Google Scholar
• Yukoners with Type 1 Diabetes receive continued support [press release]. Government of Yukon; 2020.
   Google Scholar
• Canada ADC. Public and private coverage for the FreeStyle Libre system – what you need to know. [Internet]. Available from: https://www.freestyle.abbott/ca-en/home/freestyle-libre.html. Accessed January 19, 2022.
   Google Scholar
• Province invests in new diabetes supports for young Manitobans [press release]. Available from: https://news.gov.mb.ca/news/index.html?item=52440. Accessed September 2021.
   Google Scholar
• Budget 2021–22 continues to build upon record investments in Saskatchewan health care [press release]. Government of Saskatchewan; 2021.
   Google Scholar
• Enhanced supports for Saskatchewan residents with diabetes [press release]. Government of Saskatchewan; 2021.
   Google Scholar